Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 20 studies | 42% ± 17% | |
brain | 19 studies | 36% ± 18% | |
peripheral blood | 18 studies | 52% ± 16% | |
intestine | 11 studies | 44% ± 21% | |
eye | 11 studies | 40% ± 18% | |
kidney | 8 studies | 42% ± 16% | |
liver | 7 studies | 43% ± 21% | |
bone marrow | 5 studies | 39% ± 20% | |
heart | 5 studies | 31% ± 6% | |
lymph node | 5 studies | 57% ± 15% | |
breast | 5 studies | 53% ± 16% | |
pancreas | 4 studies | 38% ± 10% | |
placenta | 4 studies | 42% ± 18% | |
uterus | 4 studies | 64% ± 10% | |
prostate | 4 studies | 36% ± 9% | |
adipose | 4 studies | 46% ± 14% | |
esophagus | 3 studies | 43% ± 31% | |
skin | 3 studies | 31% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 8861.89 | 1445 / 1445 | 100% | 89.10 | 183 / 183 |
ovary | 100% | 19169.17 | 180 / 180 | 100% | 113.53 | 430 / 430 |
skin | 100% | 11616.73 | 1809 / 1809 | 100% | 152.61 | 472 / 472 |
thymus | 100% | 12581.25 | 653 / 653 | 100% | 145.28 | 604 / 605 |
uterus | 100% | 15371.08 | 170 / 170 | 100% | 154.11 | 458 / 459 |
brain | 100% | 10170.10 | 2634 / 2642 | 100% | 166.44 | 705 / 705 |
stomach | 100% | 7725.65 | 359 / 359 | 100% | 98.06 | 285 / 286 |
intestine | 100% | 10681.70 | 966 / 966 | 100% | 113.91 | 525 / 527 |
prostate | 100% | 10615.93 | 245 / 245 | 99% | 97.52 | 499 / 502 |
lung | 100% | 10032.55 | 578 / 578 | 99% | 111.17 | 1147 / 1155 |
bladder | 100% | 11143.62 | 21 / 21 | 99% | 113.41 | 500 / 504 |
breast | 100% | 11241.52 | 459 / 459 | 99% | 144.24 | 1109 / 1118 |
adrenal gland | 100% | 8504.17 | 258 / 258 | 99% | 119.61 | 228 / 230 |
kidney | 100% | 9404.87 | 89 / 89 | 99% | 100.49 | 893 / 901 |
pancreas | 99% | 5090.18 | 325 / 328 | 99% | 98.14 | 176 / 178 |
liver | 98% | 4079.56 | 221 / 226 | 95% | 61.13 | 385 / 406 |
adipose | 100% | 10589.13 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 9167.12 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 111.64 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 180.32 | 29 / 29 |
muscle | 100% | 7575.01 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 16298.86 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 128.37 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 59.43 | 1 / 1 |
heart | 98% | 6403.29 | 844 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 94% | 7902.68 | 873 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051260 | Biological process | protein homooligomerization |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0048255 | Biological process | mRNA stabilization |
GO_1990000 | Biological process | amyloid fibril formation |
GO_0008380 | Biological process | RNA splicing |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_1905168 | Biological process | positive regulation of double-strand break repair via homologous recombination |
GO_0043484 | Biological process | regulation of RNA splicing |
GO_0005654 | Cellular component | nucleoplasm |
GO_0043232 | Cellular component | intracellular non-membrane-bounded organelle |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0003712 | Molecular function | transcription coregulator activity |
GO_0140693 | Molecular function | molecular condensate scaffold activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0003723 | Molecular function | RNA binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0003730 | Molecular function | mRNA 3'-UTR binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FUS |
Protein name | RNA-binding protein FUS (75 kDa DNA-pairing protein) (Oncogene FUS) (Oncogene TLS) (POMp75) (Translocated in liposarcoma protein) FUS RNA binding protein FUS protein (Fusion (Involved in t(1216) in malignant liposarcoma), isoform CRA_a) (Fusion, derived from t(12;16) malignant liposarcoma) Fusion (Involved in t(1216) in malignant liposarcoma) AltFUS |
Synonyms | TLS hCG_21147 |
Description | FUNCTION: DNA/RNA-binding protein that plays a role in various cellular processes such as transcription regulation, RNA splicing, RNA transport, DNA repair and damage response . Binds to nascent pre-mRNAs and acts as a molecular mediator between RNA polymerase II and U1 small nuclear ribonucleoprotein thereby coupling transcription and splicing . Binds also its own pre-mRNA and autoregulates its expression; this autoregulation mechanism is mediated by non-sense-mediated decay . Plays a role in DNA repair mechanisms by promoting D-loop formation and homologous recombination during DNA double-strand break repair . In neuronal cells, plays crucial roles in dendritic spine formation and stability, RNA transport, mRNA stability and synaptic homeostasis (By similarity). . |
Accessions | ENST00000380244.7 [P35637-2] H3BNZ4 ENST00000254108.12 [P35637-1] H3BPE7 Q6IBQ5 P35637 ENST00000566605.5 A0A823ADP9 Q8TBR3 ENST00000568685.1 |